N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine

C15H20N6 — CID 103128451

IUPACN-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine
SMILESCCNC(CCc1ccnn1C)c1cnn2ccncc12
InChIInChI=1S/C15H20N6/c1-3-17-14(5-4-12-6-7-18-20(12)2)13-10-19-21-9-8-16-11-15(13)21/h6-11,14,17H,3-5H2,1-2H3
InChIKeyZXTLFRMXBAZDHE-UHFFFAOYSA-N
MW284.37 g/mol
LogP1.75
Rot. Bonds6

About N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine

N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine (PubChem CID 103128451) has the molecular formula C15H20N6 and a molecular weight of 284.37 g/mol. Its IUPAC name is N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine.

Molecular Properties

Compound NameN-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine
PubChem CID103128451
Molecular FormulaC15H20N6
Molecular Weight284.37 g/mol
Exact Mass284.17
IUPAC NameN-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine
SMILESCCNC(CCc1ccnn1C)c1cnn2ccncc12
InChIInChI=1S/C15H20N6/c1-3-17-14(5-4-12-6-7-18-20(12)2)13-10-19-21-9-8-16-11-15(13)21/h6-11,14,17H,3-5H2,1-2H3
InChIKeyZXTLFRMXBAZDHE-UHFFFAOYSA-N
XLogP1.75
TPSA60.04 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500284.37
LogP ≤ 51.75
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-ethyl-4,4-dimethyl-1-pyrazolo[1,5-a]pyrazin-3-ylpentan-1-amine
CID 103126890
N-ethyl-1-pyrazolo[1,5-a]pyrazin-3-ylhexan-1-amine
CID 103126621
1-(3-chloro-4-pyridinyl)-N-ethyl-3-(2-methylpyrazol-3-yl)propan-1-amine
CID 103030450
2-(4-bromophenyl)-N-ethyl-1-pyrazolo[1,5-a]pyrazin-3-ylethanamine
CID 103126121
N-ethyl-3-methyl-1-pyrazolo[1,5-a]pyrazin-3-ylbutan-1-amine
CID 103125922
N-ethyl-4-methyl-1-pyrazolo[1,5-a]pyrazin-3-ylpent-4-en-1-amine
CID 103128181
N-ethyl-1-(3-methylimidazol-4-yl)-3-(2-methylpyrazol-3-yl)propan-1-amine
CID 103012068
2-(5-bromothiophen-2-yl)-N-ethyl-1-pyrazolo[1,5-a]pyrazin-3-ylethanamine
CID 103126678
N-ethyl-2-propoxy-1-pyrazolo[1,5-a]pyrazin-3-ylethanamine
CID 103127684
N-ethyl-2-(oxan-4-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylethanamine
CID 103126820
2-(2-chlorophenyl)-N-ethyl-1-pyrazolo[1,5-a]pyrazin-3-ylethanamine
CID 103126235
N-ethyl-1-pyrazolo[1,5-a]pyrazin-3-yl-2-thiophen-3-ylethanamine
CID 103126767

Frequently Asked Questions

What is the IUPAC name of N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine?
The IUPAC name of N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine (CID 103128451) is N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine.
What is the SMILES notation for N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine?
The canonical SMILES for N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine is CCNC(CCc1ccnn1C)c1cnn2ccncc12.
What is the InChIKey of N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine?
The InChIKey is ZXTLFRMXBAZDHE-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H20N6/c1-3-17-14(5-4-12-6-7-18-20(12)2)13-10-19-21-9-8-16-11-15(13)21/h6-11,14,17H,3-5H2,1-2H3.
What are the key properties of N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine?
N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine has a molecular weight of 284.37 g/mol, XLogP of 1.75, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-ethyl-3-(2-methylpyrazol-3-yl)-1-pyrazolo[1,5-a]pyrazin-3-ylpropan-1-amine is sourced from PubChem (CID 103128451), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).